These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24454305)

  • 1. Effect of subthalamic stimulation on voice and speech in Parkinson's disease: for the better or worse?
    Skodda S; Grönheit W; Schlegel U; Südmeyer M; Schnitzler A; Wojtecki L
    Front Neurol; 2014 Jan; 4():218. PubMed ID: 24454305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
    Tanaka Y; Tsuboi T; Watanabe H; Nakatsubo D; Maesawa S; Kato S; Kajita Y; Sato M; Oodake R; Hattori M; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2020; 10(1):131-140. PubMed ID: 31884493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.
    Morello ANDC; Beber BC; Fagundes VC; Cielo CA; Rieder CRM
    J Voice; 2020 May; 34(3):477-484. PubMed ID: 30454944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical Effects on Voice and Fluency in Dysarthria: Observations from Subthalamic Nucleus Stimulation.
    Sidtis D; Sidtis JJ
    J Alzheimers Dis Parkinsonism; 2017; 7(6):. PubMed ID: 29456879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
    Tanaka Y; Tsuboi T; Watanabe H; Kajita Y; Nakatsubo D; Fujimoto Y; Ohdake R; Ito M; Atsuta N; Yamamoto M; Wakabayashi T; Katsuno M; Sobue G
    J Parkinsons Dis; 2016 Oct; 6(4):811-819. PubMed ID: 27662325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is lowering stimulation frequency a feasible option for subthalamic deep brain stimulation in Parkinson's disease patients with dysarthria?
    Fabbri M; Zibetti M; Ferrero G; Accornero A; Guimaraes I; Rizzone MG; Romagnolo A; Ferreira JJ; Lopiano L
    Parkinsonism Relat Disord; 2019 Jul; 64():242-248. PubMed ID: 31060986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Hattori M; Kawabata K; Hara K; Ito M; Fujimoto Y; Nakatsubo D; Maesawa S; Kajita Y; Katsuno M; Sobue G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1547-1556. PubMed ID: 29098450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment.
    D'Alatri L; Paludetti G; Contarino MF; Galla S; Marchese MR; Bentivoglio AR
    J Voice; 2008 May; 22(3):365-72. PubMed ID: 17368837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech Intelligibility During Clinical and Low Frequency.
    Sidtis JJ; Sidtis DVL; Ramdhani R; Tagliati M
    Brain Sci; 2020 Jan; 10(1):. PubMed ID: 31906549
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular correlates of subthalamic stimulation and upper limb freezing in Parkinson's disease.
    Scholten M; Klotz R; Plewnia C; Wächter T; Mielke C; Bloem BR; Braun C; Ziemann U; Govindan RB; Gharabaghi A; Krüger R; Weiss D
    Clin Neurophysiol; 2016 Jan; 127(1):610-620. PubMed ID: 25792072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Deep Brain Stimulation of the Subthalamic Nucleus Settings on Voice Quality, Intensity, and Prosody in Parkinson's Disease: Preliminary Evidence for Speech Optimization.
    Abeyesekera A; Adams S; Mancinelli C; Knowles T; Gilmore G; Delrobaei M; Jog M
    Can J Neurol Sci; 2019 May; 46(3):287-294. PubMed ID: 30905324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.
    Klostermann F; Ehlen F; Vesper J; Nubel K; Gross M; Marzinzik F; Curio G; Sappok T
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):522-9. PubMed ID: 17766427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the pedunculopontine nucleus area in Parkinson's disease: effects on speech and intelligibility.
    Pinto S; Ferraye M; Espesser R; Fraix V; Maillet A; Guirchoum J; Layani-Zemour D; Ghio A; Chabardès S; Pollak P; Debû B
    Brain; 2014 Oct; 137(Pt 10):2759-72. PubMed ID: 25080284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived articulatory precision in patients with Parkinson's disease after deep brain stimulation of subthalamic nucleus and caudal zona incerta.
    Eklund E; Qvist J; Sandström L; Viklund F; Van Doorn J; Karlsson F
    Clin Linguist Phon; 2015 Feb; 29(2):150-66. PubMed ID: 25333411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysarthria and Speech Intelligibility Following Parkinson's Disease Globus Pallidus Internus Deep Brain Stimulation.
    Chiu SY; Tsuboi T; Hegland KW; Herndon NE; Shukla AW; Patterson A; Almeida L; Foote KD; Okun MS; Ramirez-Zamora A
    J Parkinsons Dis; 2020; 10(4):1493-1502. PubMed ID: 32955467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Acoustic Perceptual Relationship of Speech in Parkinson's Disease.
    Chiu YF; Neel A; Loux T
    J Speech Lang Hear Res; 2021 May; 64(5):1560-1570. PubMed ID: 33900806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary report on disordered speech with deep brain stimulation in individuals with Parkinson's disease.
    Dromey C; Bjarnason S
    Parkinsons Dis; 2011; 2011():796205. PubMed ID: 22046577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatments for dysarthria in Parkinson's disease.
    Pinto S; Ozsancak C; Tripoliti E; Thobois S; Limousin-Dowsey P; Auzou P
    Lancet Neurol; 2004 Sep; 3(9):547-56. PubMed ID: 15324723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic nucleus stimulation and dysarthria in Parkinson's disease: a PET study.
    Pinto S; Thobois S; Costes N; Le Bars D; Benabid AL; Broussolle E; Pollak P; Gentil M
    Brain; 2004 Mar; 127(Pt 3):602-15. PubMed ID: 14736753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.